World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   359 records for 113 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusProspective RegistrationMain ID Public TitleDate of RegistrationResults available
Not recruitingYesNCT03358394
Mindfulness-based Arabic Guided Self-help for Parents of Children With Type 1 Diabetes
24/11/2017 
RecruitingYesNCT03347916
Gabapentin Oral Solution in Decreasing Desflurane Associated Emergence Agitation
14/11/2017 
RecruitingNoNCT03326037
Study of The Association of Mutations in The NPHS2 Gene and Nephrotic Syndrome in Children and Adults in Middle East
22/10/2017 
RecruitingNoCTRI/2017/09/009894
Heat therapy(agnikarma) in Tennis Elbow
22-09-2017 
RecruitingYesDRKS00012686
Smartphone-based intervention (S.M.I.L.E.R.S.) to reduce mild to moderate depressive symptoms in Arabic-speaking clients
21/08/2017 
Not recruitingYesNCT03236779
A Comparative Study of Two Dry Needling Interventions for Plantar Heel Pain
25/07/2017 
Not recruitingYesNCT03215758
Study of Efficacy and Safety of QAW039 When Added to Standard-of-care Asthma Therapy in Patients With Uncontrolled Asthma
Recruitment statusMain IDPublic titleDate of registrationResults available
Not AvailableEUCTR2017-001273-16-DE Study of efficacy and safety of QAW039 when added to standard-of-care asthma therapy in patients with uncontrolled asthma 09/08/2017 
11/07/2017 
Not RecruitingNoTCTR20170709002
Parboiled rice improves glycemic response
07/07/2017 
RecruitingYesNCT03085810
Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS)
Recruitment statusMain IDPublic titleDate of registrationResults available
AuthorisedEUCTR2016-002937-31-SK A Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Patients With Early Stage Relapsing Remitting Multiple Sclerosis 11/05/2017 
AuthorisedEUCTR2016-002937-31-HU A Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Patients With Early Stage Relapsing Remitting Multiple Sclerosis 08/05/2017 
AuthorisedEUCTR2016-002937-31-PL A Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Patients With Early Stage Relapsing Remitting Multiple Sclerosis 10/05/2017 
AuthorisedEUCTR2016-002937-31-ES A Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Patients With Early Stage Relapsing Remitting Multiple Sclerosis 29/05/2017 
AuthorisedEUCTR2016-002937-31-SE A Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Patients With Early Stage Relapsing Remitting Multiple Sclerosis 20/04/2017 
AuthorisedEUCTR2016-002937-31-BE A Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Patients With Early Stage Relapsing Remitting Multiple Sclerosis 05/05/2017 
AuthorisedEUCTR2016-002937-31-DE A Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Patients With Early Stage Relapsing Remitting Multiple Sclerosis 02/05/2017 
AuthorisedEUCTR2016-002937-31-AT A Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Patients With Early Stage Relapsing Remitting Multiple Sclerosis 20/04/2017 
AuthorisedEUCTR2016-002937-31-DK A Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Patients With Early Stage Relapsing Remitting Multiple Sclerosis 28/04/2017 
AuthorisedEUCTR2016-002937-31-NL A Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Patients With Early Stage Relapsing Remitting Multiple Sclerosis 15/06/2017 
AuthorisedEUCTR2016-002937-31-NO A Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Patients With Early Stage Relapsing Remitting Multiple Sclerosis 18/04/2017 
AuthorisedEUCTR2016-002937-31-SI A Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Patients With Early Stage Relapsing Remitting Multiple Sclerosis 13/06/2017 
AuthorisedEUCTR2016-002937-31-PT A Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Patients With Early Stage Relapsing Remitting Multiple Sclerosis 04/05/2017 
16/03/2017 
Not RecruitingYesCTRI/2017/03/007979
Safety Assessment of Lyxumia (Lixisenatide) and Sulfonylurea as Add-on Treatment to Basal Insulin in Uncontrolled Patients With Type 2 Diabetes Mellitus Who Elect to Fast During Ramadan (LixiRam)
01-03-2017 
      
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history